Author: oncologs.com

CHAPEL HILL, North Carolina – Researchers at UNC Lineberger Comprehensive Cancer Center and colleagues have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene or “oncogene,” and how its activities impact pancreatic cancer outcomes. Their findings could help to

Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier. Credit: Cancer Discovery Using artificial intelligence technology to

Colorectal Cancer (CRC) is set to transform from a severe disease to a controllable condition through early detection and intervention. “The ultimate goal is to transform colorectal cancer from a life-threatening disease into a manageable condition through widespread, early screening and intervention”, said Dr. Zhu

Reston, VA—A new PET radiotracer enables same-day imaging of the important gastrointestinal cancer biomarker known as Claudin18.2 (CLDN18.2). Uptake of the radiotracer, 68Ga-NC-BCH, was found to correlate significantly with CLDN18.2 expression, a promising finding that could allow oncologists to optimize treatment for patients and monitor their

Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how the Epstein-Barr virus (EBV) alters how specific genes are regulated, making nasopharyngeal cancer tumours (NPC) grow faster. Credit: NTU Singapore Scientists from Nanyang Technological University, Singapore (NTU Singapore) and

The small protein ubiquitin is involved in almost every cellular process in our body: it orchestrates the stability and function of the vast majority of proteins. When it binds to other proteins, they are often released for degradation. However, this labelling can also be reversed

WORLD-FIRST STUDY INTO PRECISION MEDICINE FOR HIGH-RISK CHILDHOOD CANCER YIELDS EXTRAORDINARY RESULTS Credit: Children’s Cancer Institute Australia WORLD-FIRST STUDY INTO PRECISION MEDICINE FOR HIGH-RISK CHILDHOOD CANCER YIELDS EXTRAORDINARY RESULTS VIDEO – https://www.youtube.com/watch?v=bwyugwVwNzc In a world-first, Australian researchers and clinicians have shown that precision medicine –

Nuclear pore complexes (NPCs) are channels composed of multiple proteins that ferry molecules in and out of the nucleus, regulating many critical cellular functions, such as gene expression, chromatin organization and RNA processes that influence cell survival, proliferation, and differentiation. Credit: M. Towler and J.

“The findings of the present study reveal that aging is linked to a decline in serine racemase protein levels across various brain regions […]” Credit: 2024 Bean et al. “The findings of the present study reveal that aging is linked to a decline in serine

A short course of immunotherapy was found to be highly effective in a subset of patients with colon cancer. The treatment, which consisted of two cycles of immunotherapy prior to surgery, was effective in almost all patients. In two third of patients, there were no